Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

NCT02331251 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

81

Enrollment

OTHER

Sponsor class

Stopped PI not longer at site.

Conditions

Advanced Cancer
Breast Cancer
Sarcoma
Pancreatic Cancer
Small Cell Lung Cancer
Ovarian

Interventions

DRUG: Pembrolizumab
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Nab-paclitaxel
DRUG: Vinorelbine
DRUG: Irinotecan
DRUG: Liposomal Doxorubicin

Sponsor

Western Regional Medical Center